Religare Enterprises Ltd (RELIGARE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Religare Enterprises Ltd on NSE and BSE, with an AI summary of each filing.
Credit Rating Update of subsidiary company
Others (Uncategorized) · 05 Nov 2026, 12:37 am
CARE Ratings Reaffirms Credit Ratings for Religare Broking Limited CARE Ratings Limited has reaffirmed the credit ratings for the bank facilities of Religare Broking Limited (RBL), a wholly owned subsidiary of Religare Enterprises Limited. The rating agency reaffirmed the rating of 'CARE BBB+; Stable / CARE A2' on RBL's long-term and short-term bank facilities aggregating to ₹500.00 crore. The communication, dated 2nd Nov'26, was received by the company on 4th Nov'26, reflecting sustained credit stability across RBL's borrowing facilities.
Credit Rating Update of subsidiary company
Others (Uncategorized) · 05 Nov 2026, 12:34 am
CRISIL Upgrades Religare Broking’s Bank Facilities Ratings to BBB+ and A2+ CRISIL Ratings upgraded the credit ratings for Religare Broking Limited, a wholly owned subsidiary of Religare Enterprises Limited, covering Rs. 500 Crore in total bank loan facilities. The long-term rating was upgraded to 'CRISIL BBB+/Stable' from 'CRISIL BBB/Stable', while the short-term rating was raised to 'CRISIL A2+' from 'CRISIL A3+'. The communication, dated 2nd Nov'26, was received by the company on 4th Nov'26.
RBI''s approval for Appointment of Director(s) on the Board of the company
Change in Management · 03 Nov 2026, 10:57 pm
RBI Approves Appointment of Four Directors to Religare Enterprises Board Religare Enterprises received approval from the Reserve Bank of India on 3rd Nov'26 to appoint four Non-Executive, Non-Independent Additional Directors for a term of up to five years, effective immediately. The appointees include Dabur family members Dr. Anand Chand Burman, Aditya Chand Burman, and Mohit Burman, alongside SAMCO Group Founder and CEO Jimeet Vipul Modi. None of the appointed directors are debarred by SEBI or any other regulatory authority from holding directorships.
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 w.r.t CHIL debt Issuance
Others (Uncategorized) · 31 Oct 2026, 2:23 am
Religare Subsidiary Care Health Insurance Raises Rs 150 Crore via Subordinated Debt Care Health Insurance Limited, a material subsidiary of Religare Enterprises Limited, allotted 15,000 unsecured, listed, rated, redeemable non-convertible debentures on 30th Oct'26, aggregating to Rs 150 crore on a private placement basis. The subordinated debt carries a fixed coupon rate of 10.50% p.a., payable annually. The instruments have a 10-year tenor maturing on 30th Oct'36, with a call option exercisable by the issuer at the end of 5 years and annually thereafter. The debentures are proposed to be listed on the National Stock Exchange of India.
Appointment of Ms Dipti Jayesh Khandelwal as Company Secretary & Compliance Officer of the company w.e.f. October 31, 2026
Change in Management · 30 Oct 2026, 4:30 pm
Religare Enterprises Appoints Dipti Jayesh Khandelwal as Company Secretary and Compliance Officer Religare Enterprises Limited has approved the appointment of Ms. Dipti Jayesh Khandelwal as Company Secretary, Compliance Officer, and Key Managerial Personnel, effective 31st Oct'26. Ms. Khandelwal brings over 20 years of experience across corporate law, regulatory compliance, capital markets, and corporate governance. Her prior background includes key involvement in the Initial Public Offering of HDB Financial Services alongside extensive expertise in SEBI LODR, SEBI ICDR, FEMA compliance, M&A transactions, and board advisory.
Allotment of 22000 equity Shares pursuant exercise of equal number of options granted under REL ESOP Plan 2019
Others (Uncategorized) · 07 Oct 2026, 9:30 pm
Religare Enterprises Allots 22,000 Equity Shares Under REL ESOP Plan 2019 Religare Enterprises Limited approved the allotment of 22,000 equity shares of face value Rs. 10 each on 7th Oct'26 following the exercise of stock options under the REL ESOP Plan 2019. Consequently, the company's issued, subscribed, and paid-up equity share capital increased from Rs. 3,44,73,37,420 (34,47,33,742 shares) to Rs. 3,44,75,57,420 comprising 34,47,55,742 equity shares of Rs. 10 each.
Update about appointment in subsidiary
Others (Uncategorized) · 06 Oct 2026, 6:05 pm
Religare Finvest Appoints Gaurav Sharma as Chief Technology Officer Religare Enterprises' material subsidiary, Religare Finvest Limited (RFL), approved the appointment of Gaurav Sharma as Chief Technology Officer (CTO), effective 6th Oct'26. Sharma brings nearly 30 years of financial services and technology experience, having previously served as CTO at IIFL Finance Group since Jul'22, Group CTO at Poonawalla Fincorp from Sep'21 to Feb'22, and Head of Technology initiatives at L&T Financial Services from Jun'18 to Aug'21, driving digital transformation, cloud migrations, and AI-led lending stack modernizations.
Re-designation of Mr. Arjun Lamba as Managing Director
Change in Management · 25 Sept 2026, 10:34 pm
Religare Enterprises Shareholders Approve Re-designation of Arjun Lamba as Managing Director Religare Enterprises Limited announced that its shareholders, at the 42nd Annual General Meeting held on 24th Sep'26, approved the re-designation of Mr. Arjun Lamba as Managing Director, not liable to retire by rotation. The appointment is effective from 12th Aug'26 for the remainder of his tenure under unchanged terms and conditions. The company affirmed that Mr. Lamba is not debarred from holding the office of director pursuant to any SEBI order or other regulatory authority.
Copy Scrutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 25 Sept 2026, 10:27 pm
Proceedings of 42nd Annual General Meeting held on September 24, 2026
Annual General Meeting · 24 Sept 2026, 11:12 pm
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 18 Sept 2026, 11:48 pm
Religare Subsidiary Care Health Allots Rs. 100 Crore Subordinated NCDs Care Health Insurance Limited, a material subsidiary of Religare Enterprises Limited, allotted 10,000 unsecured, subordinated, rated, taxable, redeemable, non-convertible debentures (NCDs) aggregating to Rs. 100 Crore on a private placement basis on 18th Sep'26. The NCDs carry a fixed coupon of 10.00% p.a., payable annually, with a 10-year maturity due on 18th Sep'36 and a call option exercisable after 5 years and annually thereafter. The debentures will list on the NSE debt segment effective 22nd Sep'26. Interest servicing remains subject to IRDAI regulatory conditions.
Intimation with respect to establishment of new Corporate Office of the Company
Others (Uncategorized) · 18 Sept 2026, 11:43 pm
Religare Enterprises Establishes New Corporate Office in Mumbai Religare Enterprises Limited has established a new Corporate Office situated at Arena Space, Jogeshwari Vikhroli Link Road, Jogeshwari East, Mumbai, Maharashtra. Pursuant to Regulation 30 of SEBI (LODR) Regulations, the company confirmed that this new corporate location became fully operational effective 18th Sep'26.
As per attached disclosure
Others (Uncategorized) · 14 Sept 2026, 8:38 pm
Religare Enterprises Approves Continuation of Rajender Mohan Malla as Non-Executive Chairperson Religare Enterprises Limited's Board of Directors has approved, via circular resolution, the continuation of Independent Director Rajender Mohan Malla as the company's Non-Executive Chairperson. In line with the company's policy of appointing a rotational chairperson each calendar quarter, Mr. Malla—who initially assumed the role for the period from 1st Jul'26 to 30th Sep'26—will now continue to serve as Chairperson for the subsequent quarter effective from 1st Oct'26 through 31st Dec'26.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Motilal Oswal ELSS Tax Saver Fund
Acquisition/ Disposal of Shares · 04 Sept 2026, 4:24 pm
BRSR for FY 2025-26
Others (Uncategorized) · 03 Sept 2026, 3:45 am
Religare Enterprises FY26 BRSR: Core Segment Revenues and ESG Metrics Religare Enterprises Limited's FY26 BRSR, reported on a standalone basis, reveals a net worth of ₹2,46,615.24 Lakhs and turnover of ₹1,644.09 Lakhs. The Core Investment Company generated 46.7% of revenue from key segments: lending (16.2%), broking (11.8%), insurance (2.1%), and other investments (16.6%). Due to preceding three-year losses, REL recorded zero mandated CSR expenditure. Governance metrics highlight a nine-member board with 11% female representation and a 30-employee workforce with an 11% attrition rate. The company reported zero regulatory fines, environmental penalties, or human rights complaints during the fiscal year.
Annual Report for FY 2025-26
Others (Uncategorized) · 03 Sept 2026, 3:37 am
Notice of 42nd Annual General Meeting of the Meeting scheduled to be held on September 24, 2026
Annual General Meeting · 03 Sept 2026, 3:28 am
General Updates
Others (Uncategorized) · 01 Sept 2026, 11:00 pm
Religare: SAT Upholds SEBI Order, Dismisses Appeal Religare Enterprises informed that the Securities Appellate Tribunal (SAT), in an order dated 19th Aug'26, dismissed an appeal filed against a Securities and Exchange Board of India (SEBI) order. The original SEBI order was issued on 14th Feb'25. The SAT's decision to uphold the SEBI ruling concludes this specific legal challenge, providing a favorable resolution for the company in this matter.
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Care Health Insurance Limited, a material ....
Others (Uncategorized) · 01 Sept 2026, 10:48 pm
Religare's Subsidiary Care Health Insurance Gets Credit Rating Affirmation On 31 Aug'26, India Ratings & Research (Ind-Ra) affirmed the existing credit rating for Care Health Insurance Limited, a material subsidiary of Religare Enterprises. Ind-Ra also assigned a rating for additional subordinated debt. Both ratings were set at 'IND AA-' with a 'Stable' outlook. This action signifies a positive assessment of the subsidiary's creditworthiness and financial stability.
General Intimation About AGM
Annual General Meeting · 01 Sept 2026, 12:51 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Dhawan
Acquisition/ Disposal of Shares · 31 Aug 2026, 10:24 pm
Religare: Ashish Dhawan Increases Stake via Open Market Purchase Ashish Dhawan acquired 36,00,238 shares (1.06% stake) of Religare Enterprises via an open market purchase on 31-Aug-26. Following the transaction, his total holding of shares carrying voting rights increased from 6.35% to 7.41%. His total potential holding, including warrants, now stands at 7.28% on a fully diluted basis, up from 6.38% pre-acquisition. This disclosure was made under SEBI's SAST Regulations, 2011.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashish Dhawan
Acquisition/ Disposal of Shares · 28 Aug 2026, 10:52 pm
Religare Enterprises: Ashish Dhawan Increases Stake via Open Market Purchase Ashish Dhawan acquired 38,00,000 shares (1.11% of total capital) of Religare Enterprises via an open market purchase on 28-Aug-2026. Following the acquisition, his holding increased from 5.24% to 6.35%, representing 2,16,80,852 shares. His total potential holding, including warrants, now stands at 6.38% on a diluted basis. The disclosure was made under SEBI's Substantial Acquisition of Shares and Takeovers Regulations. Dhawan is not part of the promoter group.
General Updates
Others (Uncategorized) · 25 Aug 2026, 9:38 pm
Religare Infuses ₹100 Cr into Broking Arm via Rights Issue Religare Enterprises (REL) has invested ₹100 Cr in its wholly-owned subsidiary, Religare Broking (RBL), by subscribing to a rights issue. REL acquired 4.21 crore equity shares at a face value of ₹10 each with a premium of ₹13.75 per share. The allotment was made on 21 Aug'26. Proceeds will fund RBL's general business operations, including scaling its margin trade financing book and meeting working capital needs. RBL’s FY26 turnover was ₹315.03 Cr, down from ₹325.96 Cr in FY25. The transaction is at arm's length.
Transcript of earnings call held on Thursday, August 13, 2026 at 04.00 P.M. IST
Transcript · 19 Aug 2026, 11:42 pm
Audio Recording of earnings call held on Thursday, August 13, 2026 at 04.00 P.M. IST
Audio / Video · 14 Aug 2026, 1:42 am
Religare Makes Earnings Call Recording for Q1 FY27 Available Religare Enterprises (NSE: RELIGARE, BSE: 532915) has published the audio recording of its earnings call held on 13 Aug'26. The call discussed the operational and financial performance for the quarter ended 30 Jun'26. The recording is accessible on the company's website as per SEBI regulations.